Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei Huo

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Clinical Breast Cancer|March 16, 2024
Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast CarcinomaXiao Huang, Sarah A Anderson, Gene P Siegal, et al.
The American Journal of Surgical Pathology|July 15, 2004
Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell CarcinomaKurt T Patton, Maria S Tretiakova, Jorge L Yao, et al.
Oncotarget|September 15, 2017
Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancerHongmei Wu, Jiong Bi, Yan Peng, et al.
Cancer Management and Research|May 6, 2021
Study on the Appropriate Timing of Postoperative Adaptive Radiotherapy for High-Grade GliomaYing Cao, Du Tang, Yining Xiang, et al.
Journal of Pineal Research|February 7, 2012
Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage modelZhong Wang, Chao Ma, Cheng-Jie Meng, et al.
Journal of Molecular Neuroscience : MN|April 25, 2012
Potential contribution of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhageZhong Wang, Cheng-Jie Meng, Xu-Ming Shen, et al.
Annals of Surgical Oncology|September 25, 2014
Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancerNatasha M Rueth, Dalliah M Black, Angela R Limmer, et al.
Annals of Surgical Oncology|July 24, 2024
The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast CancerKerollos Nashat Wanis, Lianna Goetz, Alycia So, et al.
Human Pathology|April 13, 2022
Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfallTiansheng Shen, Jun Zhao, Min Zhao, et al.
BMC Nephrology|August 11, 2021
Horseshoe kidney with PLA2R-positive membranous nephropathyShuai-Shuai Shi, Xian-Zu Yang, Xiao-Ye Zhang, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Clinical Breast Cancer|March 16, 2024
Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast CarcinomaXiao Huang, Sarah A Anderson, Gene P Siegal, et al.
The American Journal of Surgical Pathology|July 15, 2004
Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell CarcinomaKurt T Patton, Maria S Tretiakova, Jorge L Yao, et al.
Oncotarget|September 15, 2017
Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancerHongmei Wu, Jiong Bi, Yan Peng, et al.
Cancer Management and Research|May 6, 2021
Study on the Appropriate Timing of Postoperative Adaptive Radiotherapy for High-Grade GliomaYing Cao, Du Tang, Yining Xiang, et al.
Journal of Pineal Research|February 7, 2012
Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage modelZhong Wang, Chao Ma, Cheng-Jie Meng, et al.
Journal of Molecular Neuroscience : MN|April 25, 2012
Potential contribution of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhageZhong Wang, Cheng-Jie Meng, Xu-Ming Shen, et al.
Annals of Surgical Oncology|September 25, 2014
Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancerNatasha M Rueth, Dalliah M Black, Angela R Limmer, et al.
Annals of Surgical Oncology|July 24, 2024
The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast CancerKerollos Nashat Wanis, Lianna Goetz, Alycia So, et al.
Human Pathology|April 13, 2022
Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfallTiansheng Shen, Jun Zhao, Min Zhao, et al.
BMC Nephrology|August 11, 2021
Horseshoe kidney with PLA2R-positive membranous nephropathyShuai-Shuai Shi, Xian-Zu Yang, Xiao-Ye Zhang, et al.
Pageof 23